Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bragiel Brothers is an active early-stage venture capital firm based in San Francisco, California, founded by brothers Dan Bragiel and Paul Bragiel. The firm invests primarily in pre-seed, seed, and Series A startups across multiple technology sectors, with some exposure to healthcare, healthtech, medtech, and life sciences through portfolio investments rather than internal drug development. Available sources characterize it as an investment organization rather than an operating biotech, pharma, or healthcare company. Because it is a VC firm, it does not appear to have a therapeutic pipeline, clinical-stage assets, or proprietary drug programs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bragiel Brothers.